Discuss the suitability of current regulations for biotechnology medicinal products globally under the following four topics:
(i) Fitness for purpose
(ii) Impact on, and response to innovation
(iii) Impact on the access of medicines to patients
(iv) Any other suitable topic(s)
You should provide, where relevant, examples and identify the regulations